This inventor holds 4 USPTO granted patents. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 1998-2002.
Company Filing History:
Years Active: 1998-2002
Title: Oliver Kemper: Innovator in TNF Receptor Research
Introduction
Oliver Kemper is a notable inventor based in Bockenheim, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of tumor necrosis factor (TNF) receptors. With a total of 4 patents to his name, Kemper's work has implications for understanding and modulating TNF function.
Latest Patents
Kemper's latest patents include innovative sequences related to TNF receptors. One of his key patents is the TNF receptor promoter, which provides a promoter sequence of the human p55 TNF-R gene. This patent also details sequence motifs and motif regions contained within the promoter sequence. Additionally, methods for preparing these motifs or motif regions and their use in the modulation of TNF function are outlined. Another significant patent involves p75 TNF receptor promoters, further expanding the understanding of TNF receptor biology.
Career Highlights
Oliver Kemper is associated with Yeda Research and Development Co. Ltd., where he has been instrumental in advancing research in his field. His work has not only contributed to scientific knowledge but also has potential applications in therapeutic development.
Collaborations
Kemper has collaborated with esteemed colleagues such as David Wallach and Peter Kuhnert. These collaborations have enriched his research and have led to advancements in the understanding of TNF receptors.
Conclusion
In summary, Oliver Kemper is a prominent inventor whose work on TNF receptor promoters has significant implications for biotechnology. His contributions continue to influence the field and pave the way for future innovations.